Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Lymphoid 2Dermatologic 1

Conditions

Neoplasms 41Breast Neoplasms 40Lung Neoplasms 25Carcinoma, Non-Small-Cell Lung 20Colorectal Neoplasms 19Uterine Cervical Neoplasms 13Prostatic Neoplasms 13Head and Neck Neoplasms 11Carcinoma, Hepatocellular 11Pancreatic Neoplasms 10Melanoma 10Ovarian Neoplasms 9Neoplastic Cells, Circulating 7Myelodysplastic Syndromes 7Glioma 7Esophageal Neoplasms 7Endometrial Neoplasms 7Brain Neoplasms 7Sarcoma 6Multiple Myeloma 6Gastrointestinal Neoplasms 6Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Neoplasm Metastasis 5Leukemia, Myeloid, Acute 5Disease 5Colonic Neoplasms 5Uveal Melanoma 4Skin Neoplasms 4Neoplasm, Residual 4

Interventions

mogamulizumab 4Specimen Handling 3Immunoglobulin G 3Disulfides 3Cyclophosphamide 3Biopsy 3pembrolizumab 2fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Tacrolimus 2Photopheresis 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Mycophenolic Acid 2Magnetic Resonance Spectroscopy 2Busulfan 2Blood Specimen Collection 2talimogene laherparepvec 1magrolimab 1duvelisib 1durvalumab 1Vincristine 1Valganciclovir 1Urine Specimen Collection 1Transplantation 1Therapeutics 1Sirolimus 1Radiotherapy 1Prednisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sezary Syndrome × Blood Specimen Collection × 1 year × Clear all
NCT07477769 2026-03-17

NIPALYMPHO

Assistance Publique - Hôpitaux de Paris

Not yet recruiting
10 enrolled
Lymphoid

Sezary Syndrome, Ichthyosis, Lamellar

NCT00177268 2025-12-30

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

University of Pittsburgh

Recruiting
200 enrolled
DermatologicLymphoid

Dermatitis, Atopic, Eczema, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡